Skip to main content
. 2015 Mar 16;10(3):e0119497. doi: 10.1371/journal.pone.0119497

Table 2. AML subtypes, tumor markers and cytogenetic abnormalities.

Variables N = 183
FAB subtypes
M0 (%) 42.6
M1 (%) 6.6
M2 (%) 16.9
M3 (%) 15.3
M4 (%) 8.7
M5 (%) 8.7
M6 (%) 0
M7 (%) 1.1
Tumor markers
CD34 (%) 54.1
Cytogenetic abnormalities
CALGB adverse profile (%) 28.4
CALGB intermediate profile (%) 56.8
CALGB favorable profile (%) 14.8
Gene mutations
NPM1 (%) 6
FLT3 (%) 6.6